The global market for Blood & Tissue Kit was valued at US$ 365 million in the year 2024 and is projected to reach a revised size of US$ 513 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Blood & Tissue Kit Market

Blood & Tissue Kit is a specialized tool designed for the collection, preservation, and analysis of biological samples from blood and tissue. These kits are widely used in medical, research, and forensic applications to ensure the proper handling and integrity of biological specimens. They are tailored for specific types of analyses, including genetic testing, biomarker analysis, histology, and diagnostic procedures.

North American market for Blood & Tissue Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Blood & Tissue Kit is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Blood & Tissue Kit include QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blood & Tissue Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood & Tissue Kit.

The Blood & Tissue Kit market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood & Tissue Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood & Tissue Kit manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Blood & Tissue Kit Market Report

Report Metric	Details
Report Name	Blood & Tissue Kit Market
Accounted market size in year	US$ 365 million
Forecasted market size in 2031	US$ 513 million
CAGR	6.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Whole Blood Plasma or Serum Buffy Coat
Segment by Application	R&D Organisations Biotechnology Companies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, Bio-Rad, Omega Bio-tek, Geneaid, Lucigen (Biosearch Technologies), Norgen, MGI Tech Co., Ltd., BioVision
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blood & Tissue Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blood & Tissue Kit in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Blood & Tissue Kit Market growing?

Ans: The Blood & Tissue Kit Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Blood & Tissue Kit Market size in 2031?

Ans: The Blood & Tissue Kit Market size in 2031 will be US$ 513 million.

Who are the main players in the Blood & Tissue Kit Market report?

Ans: The main players in the Blood & Tissue Kit Market are QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, Bio-Rad, Omega Bio-tek, Geneaid, Lucigen (Biosearch Technologies), Norgen, MGI Tech Co., Ltd., BioVision

What are the Application segmentation covered in the Blood & Tissue Kit Market report?

Ans: The Applications covered in the Blood & Tissue Kit Market report are R&D Organisations, Biotechnology Companies

What are the Type segmentation covered in the Blood & Tissue Kit Market report?

Ans: The Types covered in the Blood & Tissue Kit Market report are Whole Blood, Plasma or Serum, Buffy Coat

1 Blood & Tissue Kit Market Overview

1.1 Product Definition

1.2 Blood & Tissue Kit by Type

1.2.1 Global Blood & Tissue Kit Market Value Comparison by Type (2024 VS 2031)

1.2.2 Whole Blood

1.2.3 Plasma or Serum

1.2.4 Buffy Coat

1.3 Blood & Tissue Kit by Application

1.3.1 Global Blood & Tissue Kit Market Value by Application (2024 VS 2031)

1.3.2 R&D Organisations

1.3.3 Biotechnology Companies

1.4 Global Blood & Tissue Kit Market Size Estimates and Forecasts

1.4.1 Global Blood & Tissue Kit Revenue 2020-2031

1.4.2 Global Blood & Tissue Kit Sales 2020-2031

1.4.3 Global Blood & Tissue Kit Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Blood & Tissue Kit Market Competition by Manufacturers

2.1 Global Blood & Tissue Kit Sales Market Share by Manufacturers (2020-2025)

2.2 Global Blood & Tissue Kit Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Blood & Tissue Kit Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Blood & Tissue Kit, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Blood & Tissue Kit, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Blood & Tissue Kit, Product Type & Application

2.7 Global Key Manufacturers of Blood & Tissue Kit, Date of Enter into This Industry

2.8 Global Blood & Tissue Kit Market Competitive Situation and Trends

2.8.1 Global Blood & Tissue Kit Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Blood & Tissue Kit Players Market Share by Revenue

2.8.3 Global Blood & Tissue Kit Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Blood & Tissue Kit Market Scenario by Region

3.1 Global Blood & Tissue Kit Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Blood & Tissue Kit Sales by Region: 2020-2031

3.2.1 Global Blood & Tissue Kit Sales by Region: 2020-2025

3.2.2 Global Blood & Tissue Kit Sales by Region: 2026-2031

3.3 Global Blood & Tissue Kit Revenue by Region: 2020-2031

3.3.1 Global Blood & Tissue Kit Revenue by Region: 2020-2025

3.3.2 Global Blood & Tissue Kit Revenue by Region: 2026-2031

3.4 North America Blood & Tissue Kit Market Facts & Figures by Country

3.4.1 North America Blood & Tissue Kit Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Blood & Tissue Kit Sales by Country (2020-2031)

3.4.3 North America Blood & Tissue Kit Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Blood & Tissue Kit Market Facts & Figures by Country

3.5.1 Europe Blood & Tissue Kit Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Blood & Tissue Kit Sales by Country (2020-2031)

3.5.3 Europe Blood & Tissue Kit Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Blood & Tissue Kit Market Facts & Figures by Region

3.6.1 Asia Pacific Blood & Tissue Kit Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Blood & Tissue Kit Sales by Region (2020-2031)

3.6.3 Asia Pacific Blood & Tissue Kit Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Blood & Tissue Kit Market Facts & Figures by Country

3.7.1 Latin America Blood & Tissue Kit Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Blood & Tissue Kit Sales by Country (2020-2031)

3.7.3 Latin America Blood & Tissue Kit Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Blood & Tissue Kit Market Facts & Figures by Country

3.8.1 Middle East and Africa Blood & Tissue Kit Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Blood & Tissue Kit Sales by Country (2020-2031)

3.8.3 Middle East and Africa Blood & Tissue Kit Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Blood & Tissue Kit Sales by Type (2020-2031)

4.1.1 Global Blood & Tissue Kit Sales by Type (2020-2025)

4.1.2 Global Blood & Tissue Kit Sales by Type (2026-2031)

4.1.3 Global Blood & Tissue Kit Sales Market Share by Type (2020-2031)

4.2 Global Blood & Tissue Kit Revenue by Type (2020-2031)

4.2.1 Global Blood & Tissue Kit Revenue by Type (2020-2025)

4.2.2 Global Blood & Tissue Kit Revenue by Type (2026-2031)

4.2.3 Global Blood & Tissue Kit Revenue Market Share by Type (2020-2031)

4.3 Global Blood & Tissue Kit Price by Type (2020-2031)

5 Segment by Application

5.1 Global Blood & Tissue Kit Sales by Application (2020-2031)

5.1.1 Global Blood & Tissue Kit Sales by Application (2020-2025)

5.1.2 Global Blood & Tissue Kit Sales by Application (2026-2031)

5.1.3 Global Blood & Tissue Kit Sales Market Share by Application (2020-2031)

5.2 Global Blood & Tissue Kit Revenue by Application (2020-2031)

5.2.1 Global Blood & Tissue Kit Revenue by Application (2020-2025)

5.2.2 Global Blood & Tissue Kit Revenue by Application (2026-2031)

5.2.3 Global Blood & Tissue Kit Revenue Market Share by Application (2020-2031)

5.3 Global Blood & Tissue Kit Price by Application (2020-2031)

6 Key Companies Profiled

6.1 QIAGEN

6.1.1 QIAGEN Company Information

6.1.2 QIAGEN Description and Business Overview

6.1.3 QIAGEN Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.1.4 QIAGEN Blood & Tissue Kit Product Portfolio

6.1.5 QIAGEN Recent Developments/Updates

6.2 Thermo Fisher Scientific

6.2.1 Thermo Fisher Scientific Company Information

6.2.2 Thermo Fisher Scientific Description and Business Overview

6.2.3 Thermo Fisher Scientific Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Thermo Fisher Scientific Blood & Tissue Kit Product Portfolio

6.2.5 Thermo Fisher Scientific Recent Developments/Updates

6.3 Sigma-Aldrich (Merck)

6.3.1 Sigma-Aldrich (Merck) Company Information

6.3.2 Sigma-Aldrich (Merck) Description and Business Overview

6.3.3 Sigma-Aldrich (Merck) Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Sigma-Aldrich (Merck) Blood & Tissue Kit Product Portfolio

6.3.5 Sigma-Aldrich (Merck) Recent Developments/Updates

6.4 Roche

6.4.1 Roche Company Information

6.4.2 Roche Description and Business Overview

6.4.3 Roche Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Roche Blood & Tissue Kit Product Portfolio

6.4.5 Roche Recent Developments/Updates

6.5 Axygen (Corning)

6.5.1 Axygen (Corning) Company Information

6.5.2 Axygen (Corning) Description and Business Overview

6.5.3 Axygen (Corning) Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Axygen (Corning) Blood & Tissue Kit Product Portfolio

6.5.5 Axygen (Corning) Recent Developments/Updates

6.6 Analytik Jena

6.6.1 Analytik Jena Company Information

6.6.2 Analytik Jena Description and Business Overview

6.6.3 Analytik Jena Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Analytik Jena Blood & Tissue Kit Product Portfolio

6.6.5 Analytik Jena Recent Developments/Updates

6.7 Promega

6.7.1 Promega Company Information

6.7.2 Promega Description and Business Overview

6.7.3 Promega Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Promega Blood & Tissue Kit Product Portfolio

6.7.5 Promega Recent Developments/Updates

6.8 Zymo Research

6.8.1 Zymo Research Company Information

6.8.2 Zymo Research Description and Business Overview

6.8.3 Zymo Research Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Zymo Research Blood & Tissue Kit Product Portfolio

6.8.5 Zymo Research Recent Developments/Updates

6.9 Illumina

6.9.1 Illumina Company Information

6.9.2 Illumina Description and Business Overview

6.9.3 Illumina Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Illumina Blood & Tissue Kit Product Portfolio

6.9.5 Illumina Recent Developments/Updates

6.10 Macherey-Nagel

6.10.1 Macherey-Nagel Company Information

6.10.2 Macherey-Nagel Description and Business Overview

6.10.3 Macherey-Nagel Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Macherey-Nagel Blood & Tissue Kit Product Portfolio

6.10.5 Macherey-Nagel Recent Developments/Updates

6.11 Bio-Rad

6.11.1 Bio-Rad Company Information

6.11.2 Bio-Rad Description and Business Overview

6.11.3 Bio-Rad Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Bio-Rad Blood & Tissue Kit Product Portfolio

6.11.5 Bio-Rad Recent Developments/Updates

6.12 Omega Bio-tek

6.12.1 Omega Bio-tek Company Information

6.12.2 Omega Bio-tek Description and Business Overview

6.12.3 Omega Bio-tek Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Omega Bio-tek Blood & Tissue Kit Product Portfolio

6.12.5 Omega Bio-tek Recent Developments/Updates

6.13 Geneaid

6.13.1 Geneaid Company Information

6.13.2 Geneaid Description and Business Overview

6.13.3 Geneaid Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Geneaid Blood & Tissue Kit Product Portfolio

6.13.5 Geneaid Recent Developments/Updates

6.14 Lucigen (Biosearch Technologies)

6.14.1 Lucigen (Biosearch Technologies) Company Information

6.14.2 Lucigen (Biosearch Technologies) Description and Business Overview

6.14.3 Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Lucigen (Biosearch Technologies) Blood & Tissue Kit Product Portfolio

6.14.5 Lucigen (Biosearch Technologies) Recent Developments/Updates

6.15 Norgen

6.15.1 Norgen Company Information

6.15.2 Norgen Description and Business Overview

6.15.3 Norgen Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Norgen Blood & Tissue Kit Product Portfolio

6.15.5 Norgen Recent Developments/Updates

6.16 MGI Tech Co., Ltd.

6.16.1 MGI Tech Co., Ltd. Company Information

6.16.2 MGI Tech Co., Ltd. Description and Business Overview

6.16.3 MGI Tech Co., Ltd. Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.16.4 MGI Tech Co., Ltd. Blood & Tissue Kit Product Portfolio

6.16.5 MGI Tech Co., Ltd. Recent Developments/Updates

6.17 BioVision

6.17.1 BioVision Company Information

6.17.2 BioVision Description and Business Overview

6.17.3 BioVision Blood & Tissue Kit Sales, Revenue and Gross Margin (2020-2025)

6.17.4 BioVision Blood & Tissue Kit Product Portfolio

6.17.5 BioVision Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Blood & Tissue Kit Industry Chain Analysis

7.2 Blood & Tissue Kit Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Blood & Tissue Kit Production Mode & Process Analysis

7.4 Blood & Tissue Kit Sales and Marketing

7.4.1 Blood & Tissue Kit Sales Channels

7.4.2 Blood & Tissue Kit Distributors

7.5 Blood & Tissue Kit Customer Analysis

8 Blood & Tissue Kit Market Dynamics

8.1 Blood & Tissue Kit Industry Trends

8.2 Blood & Tissue Kit Market Drivers

8.3 Blood & Tissue Kit Market Challenges

8.4 Blood & Tissue Kit Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Qiagen NV

Thermo Fisher Scientific

Lucigen (Biosearch Technologies)

Norgen

MGI Tech Co., Ltd

BioVision

List of Tables

Table 1. Global Blood & Tissue Kit Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Blood & Tissue Kit Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Blood & Tissue Kit Market Competitive Situation by Manufacturers in 2024

Table 4. Global Blood & Tissue Kit Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Blood & Tissue Kit Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Blood & Tissue Kit Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Blood & Tissue Kit Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Blood & Tissue Kit Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Blood & Tissue Kit, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Blood & Tissue Kit, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Blood & Tissue Kit, Product Type & Application

Table 12. Global Key Manufacturers of Blood & Tissue Kit, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Blood & Tissue Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood & Tissue Kit as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Blood & Tissue Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Blood & Tissue Kit Sales by Region (2020-2025) & (K Units)

Table 18. Global Blood & Tissue Kit Sales Market Share by Region (2020-2025)

Table 19. Global Blood & Tissue Kit Sales by Region (2026-2031) & (K Units)

Table 20. Global Blood & Tissue Kit Sales Market Share by Region (2026-2031)

Table 21. Global Blood & Tissue Kit Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Blood & Tissue Kit Revenue Market Share by Region (2020-2025)

Table 23. Global Blood & Tissue Kit Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Blood & Tissue Kit Revenue Market Share by Region (2026-2031)

Table 25. North America Blood & Tissue Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Blood & Tissue Kit Sales by Country (2020-2025) & (K Units)

Table 27. North America Blood & Tissue Kit Sales by Country (2026-2031) & (K Units)

Table 28. North America Blood & Tissue Kit Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Blood & Tissue Kit Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Blood & Tissue Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Blood & Tissue Kit Sales by Country (2020-2025) & (K Units)

Table 32. Europe Blood & Tissue Kit Sales by Country (2026-2031) & (K Units)

Table 33. Europe Blood & Tissue Kit Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Blood & Tissue Kit Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Blood & Tissue Kit Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Blood & Tissue Kit Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Blood & Tissue Kit Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Blood & Tissue Kit Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Blood & Tissue Kit Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Blood & Tissue Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Blood & Tissue Kit Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Blood & Tissue Kit Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Blood & Tissue Kit Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Blood & Tissue Kit Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Blood & Tissue Kit Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Blood & Tissue Kit Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Blood & Tissue Kit Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Blood & Tissue Kit Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Blood & Tissue Kit Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Blood & Tissue Kit Sales (K Units) by Type (2020-2025)

Table 51. Global Blood & Tissue Kit Sales (K Units) by Type (2026-2031)

Table 52. Global Blood & Tissue Kit Sales Market Share by Type (2020-2025)

Table 53. Global Blood & Tissue Kit Sales Market Share by Type (2026-2031)

Table 54. Global Blood & Tissue Kit Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Blood & Tissue Kit Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Blood & Tissue Kit Revenue Market Share by Type (2020-2025)

Table 57. Global Blood & Tissue Kit Revenue Market Share by Type (2026-2031)

Table 58. Global Blood & Tissue Kit Price (US$/Unit) by Type (2020-2025)

Table 59. Global Blood & Tissue Kit Price (US$/Unit) by Type (2026-2031)

Table 60. Global Blood & Tissue Kit Sales (K Units) by Application (2020-2025)

Table 61. Global Blood & Tissue Kit Sales (K Units) by Application (2026-2031)

Table 62. Global Blood & Tissue Kit Sales Market Share by Application (2020-2025)

Table 63. Global Blood & Tissue Kit Sales Market Share by Application (2026-2031)

Table 64. Global Blood & Tissue Kit Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Blood & Tissue Kit Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Blood & Tissue Kit Revenue Market Share by Application (2020-2025)

Table 67. Global Blood & Tissue Kit Revenue Market Share by Application (2026-2031)

Table 68. Global Blood & Tissue Kit Price (US$/Unit) by Application (2020-2025)

Table 69. Global Blood & Tissue Kit Price (US$/Unit) by Application (2026-2031)

Table 70. QIAGEN Company Information

Table 71. QIAGEN Description and Business Overview

Table 72. QIAGEN Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. QIAGEN Blood & Tissue Kit Product

Table 74. QIAGEN Recent Developments/Updates

Table 75. Thermo Fisher Scientific Company Information

Table 76. Thermo Fisher Scientific Description and Business Overview

Table 77. Thermo Fisher Scientific Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Thermo Fisher Scientific Blood & Tissue Kit Product

Table 79. Thermo Fisher Scientific Recent Developments/Updates

Table 80. Sigma-Aldrich (Merck) Company Information

Table 81. Sigma-Aldrich (Merck) Description and Business Overview

Table 82. Sigma-Aldrich (Merck) Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Sigma-Aldrich (Merck) Blood & Tissue Kit Product

Table 84. Sigma-Aldrich (Merck) Recent Developments/Updates

Table 85. Roche Company Information

Table 86. Roche Description and Business Overview

Table 87. Roche Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Roche Blood & Tissue Kit Product

Table 89. Roche Recent Developments/Updates

Table 90. Axygen (Corning) Company Information

Table 91. Axygen (Corning) Description and Business Overview

Table 92. Axygen (Corning) Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Axygen (Corning) Blood & Tissue Kit Product

Table 94. Axygen (Corning) Recent Developments/Updates

Table 95. Analytik Jena Company Information

Table 96. Analytik Jena Description and Business Overview

Table 97. Analytik Jena Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Analytik Jena Blood & Tissue Kit Product

Table 99. Analytik Jena Recent Developments/Updates

Table 100. Promega Company Information

Table 101. Promega Description and Business Overview

Table 102. Promega Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Promega Blood & Tissue Kit Product

Table 104. Promega Recent Developments/Updates

Table 105. Zymo Research Company Information

Table 106. Zymo Research Description and Business Overview

Table 107. Zymo Research Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Zymo Research Blood & Tissue Kit Product

Table 109. Zymo Research Recent Developments/Updates

Table 110. Illumina Company Information

Table 111. Illumina Description and Business Overview

Table 112. Illumina Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Illumina Blood & Tissue Kit Product

Table 114. Illumina Recent Developments/Updates

Table 115. Macherey-Nagel Company Information

Table 116. Macherey-Nagel Description and Business Overview

Table 117. Macherey-Nagel Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Macherey-Nagel Blood & Tissue Kit Product

Table 119. Macherey-Nagel Recent Developments/Updates

Table 120. Bio-Rad Company Information

Table 121. Bio-Rad Description and Business Overview

Table 122. Bio-Rad Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Bio-Rad Blood & Tissue Kit Product

Table 124. Bio-Rad Recent Developments/Updates

Table 125. Omega Bio-tek Company Information

Table 126. Omega Bio-tek Description and Business Overview

Table 127. Omega Bio-tek Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Omega Bio-tek Blood & Tissue Kit Product

Table 129. Omega Bio-tek Recent Developments/Updates

Table 130. Geneaid Company Information

Table 131. Geneaid Description and Business Overview

Table 132. Geneaid Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Geneaid Blood & Tissue Kit Product

Table 134. Geneaid Recent Developments/Updates

Table 135. Lucigen (Biosearch Technologies) Company Information

Table 136. Lucigen (Biosearch Technologies) Description and Business Overview

Table 137. Lucigen (Biosearch Technologies) Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Lucigen (Biosearch Technologies) Blood & Tissue Kit Product

Table 139. Lucigen (Biosearch Technologies) Recent Developments/Updates

Table 140. Norgen Company Information

Table 141. Norgen Description and Business Overview

Table 142. Norgen Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Norgen Blood & Tissue Kit Product

Table 144. Norgen Recent Developments/Updates

Table 145. MGI Tech Co., Ltd. Company Information

Table 146. MGI Tech Co., Ltd. Description and Business Overview

Table 147. MGI Tech Co., Ltd. Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 148. MGI Tech Co., Ltd. Blood & Tissue Kit Product

Table 149. MGI Tech Co., Ltd. Recent Developments/Updates

Table 150. BioVision Company Information

Table 151. BioVision Description and Business Overview

Table 152. BioVision Blood & Tissue Kit Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 153. BioVision Blood & Tissue Kit Product

Table 154. BioVision Recent Developments/Updates

Table 155. Key Raw Materials Lists

Table 156. Raw Materials Key Suppliers Lists

Table 157. Blood & Tissue Kit Distributors List

Table 158. Blood & Tissue Kit Customers List

Table 159. Blood & Tissue Kit Market Trends

Table 160. Blood & Tissue Kit Market Drivers

Table 161. Blood & Tissue Kit Market Challenges

Table 162. Blood & Tissue Kit Market Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

Table 166. Authors List of This Report

List of Figures

Figure 1. Product Picture of Blood & Tissue Kit

Figure 2. Global Blood & Tissue Kit Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Blood & Tissue Kit Market Share by Type: 2024 & 2031

Figure 4. Whole Blood Product Picture

Figure 5. Plasma or Serum Product Picture

Figure 6. Buffy Coat Product Picture

Figure 7. Global Blood & Tissue Kit Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Blood & Tissue Kit Market Share by Application: 2024 & 2031

Figure 9. R&D Organisations

Figure 10. Biotechnology Companies

Figure 11. Global Blood & Tissue Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Blood & Tissue Kit Market Size (2020-2031) & (US$ Million)

Figure 13. Global Blood & Tissue Kit Sales (2020-2031) & (K Units)

Figure 14. Global Blood & Tissue Kit Average Price (US$/Unit) & (2020-2031)

Figure 15. Blood & Tissue Kit Report Years Considered

Figure 16. Blood & Tissue Kit Sales Share by Manufacturers in 2024

Figure 17. Global Blood & Tissue Kit Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Blood & Tissue Kit Players: Market Share by Revenue in Blood & Tissue Kit in 2024

Figure 19. Blood & Tissue Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Blood & Tissue Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Blood & Tissue Kit Sales Market Share by Country (2020-2031)

Figure 22. North America Blood & Tissue Kit Revenue Market Share by Country (2020-2031)

Figure 23. United States Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Blood & Tissue Kit Sales Market Share by Country (2020-2031)

Figure 26. Europe Blood & Tissue Kit Revenue Market Share by Country (2020-2031)

Figure 27. Germany Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Blood & Tissue Kit Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Blood & Tissue Kit Revenue Market Share by Region (2020-2031)

Figure 34. China Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Blood & Tissue Kit Sales Market Share by Country (2020-2031)

Figure 42. Latin America Blood & Tissue Kit Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Blood & Tissue Kit Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Blood & Tissue Kit Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Blood & Tissue Kit Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Blood & Tissue Kit by Type (2020-2031)

Figure 53. Global Revenue Market Share of Blood & Tissue Kit by Type (2020-2031)

Figure 54. Global Blood & Tissue Kit Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Blood & Tissue Kit by Application (2020-2031)

Figure 56. Global Revenue Market Share of Blood & Tissue Kit by Application (2020-2031)

Figure 57. Global Blood & Tissue Kit Price (US$/Unit) by Application (2020-2031)

Figure 58. Blood & Tissue Kit Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions